All Substitutes
Loading...
Disclaimer
Did you find this information helpful?
Zafimove 50mg Tablet
Prescription Required
Salt Composition : Safinamide
Manufacturer : TORRENT PHARMACEUTICALS LTD
Origin of Medicine : India
10 Tablet(s) In A Strip
Introduction to Zafimove 50mg Tablet
Zafimove 50mg Tablet contains active components called Safinamide. This medication is used to treat Parkinson's disease. It helps reduce the symptoms of Parkinson's disease(a neurodegenerative disorder that affects movement), such as tremors, stiffness, and slowness of movement. Individuals who have had a hypersensitivity or allergic reaction to Zafimove 50mg Tablet or any of its components should avoid using this medication. Avoid using it concurrently or within 14 days of discontinuing other MAO inhibitors, as it can lead to potentially serious drug interactions and increase the risk of serotonin syndrome. It might not be suitable for individuals with pheochromocytoma due to its potential to increase blood pressure and stimulate the release of certain hormones. Individuals with kidney impairment should use Zafimove 50mg Tablet with caution. The safety and efficacy of Zafimove 50mg Tablet in children have not been established, so it is not typically recommended for children. This mediation can be used in older adults, but caution may be needed due to age-related changes in drug metabolism and the potential for other health issues.
Uses of Zafimove 50mg Tablet
- Parkinson's disease treatment
Therapeutic Effects of Zafimove 50mg Tablet
Zafimove 50mg Tablet works by increasing levels of dopamine in the brain, helping to manage symptoms like tremors, stiffness, and slowness of movement associated with Parkinson's.
Interaction of Zafimove 50mg Tablet with other drugs
Inform the doctor about your medicines, including prescription, over-the-counter, nutritional or vitamin supplements, and herbal products. Certain medications may interact with the Zafimove 50mg Tablet, reducing effectiveness by causing undesirable side effects.
More Information about Zafimove 50mg Tablet
- Stored at controlled room temperature between 20°C to 25°C
- Keep away from moisture, heat, and light.
- It should not be frozen.
- Keep away from children and pets.
How to consume Zafimove 50mg Tablet
Zafimove 50mg Tablet is administered orally, meaning you take it by mouth. The recommended dosage may be adjusted by a healthcare professional as needed.
Safety Advices for Zafimove 50mg Tablet
Pregnancy
Talk to your doctor before taking Zafimove 50mg Tablet if you are pregnant or trying to become pregnant, as its safety during pregnancy has not been fully established.
Breast Feeding
There is limited data on whether Zafimove 50mg Tablet passes into breast milk. Consult your doctor for advice before taking this medication if you are a breastfeeding mother.
Lungs
Consult your health care provider before taking Zafimove 50mg Tablet if you have lung disease.
Liver
If you have a liver condition or are concerned about the safety of the Zafimove 50mg Tablet. In that case, it is recommended that you consult your healthcare provider for personalized advice.
Alcohol
Drinking alcohol while taking Zafimove 50mg Tablet may increase the risk of certain side effects, such as dizziness or drowsiness so it is not safe to take with alcohol.
Driving
Zafimove 50mg Tablet might cause dizziness, drowsiness, or other side effects that could impair one's ability to drive or operate machinery. Consult your healthcare provider before taking it after driving.
Side Effects of Zafimove 50mg Tablet
Zafimove 50mg Tablet causes side effects like all medications, although not everyone will experience them.
Serious:
- Allergic reactions
- Hallucinations or psychiatric symptoms
- Serotonin syndrome
- Changes in liver function
Common:
- Nausea
- Insomnia
- Dizziness
- Headache
- Uncontrolled movements
Word of Advice
Inform your doctor about all medications, supplements, or herbal products you're taking to avoid potential interactions. Caution is advised when using Zafimove 50mg Tablet alongside other medications that also raise serotonin levels, as it could lead to serotonin syndrome. Watch for symptoms like confusion, hallucinations, rapid heart rate, and high blood pressure. Regular monitoring of blood pressure is recommended, especially at the start of treatment or with any dosage adjustments. Inform your doctor if you notice any unusual changes in your mental health.
FAQs
Q 1. Can Zafimove 50mg Tablet be used alone to treat Parkinson's?
Zafimove 50mg Tablet is often used in combination with other Parkinson's medications, especially levodopa/carbidopa, to enhance their effects and manage motor fluctuations.
Q 2. What are the common side effects of Zafimove 50mg Tablet?
Common side effects of Zafimove 50mg Tablet may include nausea, insomnia, dizziness, headaches, and uncontrolled movements.
Q 3. What should I do if I miss a dose of Zafimove 50mg Tablet?
If you miss a dose of Zafimove 50mg Tablet, take it as soon as you remember. However, if it's almost time for your next scheduled dose, skip the missed dose and continue with your regular dosing schedule. Do not take a double dose to make up for the missed one.
Q 4. Can Zafimove 50mg Tablet be stopped suddenly?
It is important not to stop taking Zafimove 50mg Tablet abruptly without consulting your healthcare provider. They can guide tapering off the medication if necessary.
Q 5. How often should I have check-ups while on Zafimove 50mg Tablet?
The frequency of check-ups varies based on individual needs and response to the Zafimove 50mg Tablet. Your doctor will determine the appropriate schedule for monitoring your condition while taking this medication.
Fact Box of Zafimove 50mg Tablet
Molecule name: Safinamide | Therapeutic class: Antiparkinsonian agent |
Pharmacological class: Monoamine oxidase B (MAO-B) inhibitors | Indications: Parkinson's disease treatment |
References
- U.S FDA (Food and Drug Safety Administration), [ Last Revised 21st March 2017], [Accessed on 29th Dec 2023], https://www.fda.gov/news-events/press-announcements/fda-approves-drug-treat-parkinsons-disease
- Baker DE, Kim AP. Formulary Drug Review: Zafimove 50mg Tablet. Hosp Pharm.[Published on 2017 September] [Accessed on 29th Dec 2023]
Disclaimer
